By Abigail Townsend
Date: Wednesday 13 May 2026
(Sharecast News) - Shares in Merck sparked on Wednesday, after the German pharmaceuticals and technology giant boosted guidance on the back of a "solid" first quarter.
By Benjamin Chiou
Date: Thursday 30 Apr 2026
(Sharecast News) - Merck & Co beat market forecasts with its first-quarter results on Thursday and raised its full-year guidance on the back of strong growth for Keytruda, its flagship humanised monoclonal antibody (PD-1 inhibitor) used to treat 18 types of cancer.
By Michele Maatouk
Date: Wednesday 25 Mar 2026
(Sharecast News) - Merck said on Wednesday that it has agreed to buy Terns Pharmaceuticals, a clinical-stage oncology company, for $6.7bn.
| Currency | US Dollars |
| Share Price | $ 113.45 |
| Change Today | $ 1.08 |
| % Change | 0.96 % |
| 52 Week High | $123.18 |
| 52 Week Low | $73.47 |
| Volume | 7,686,961 |
| Shares Issued | 2,474.63m |
| Market Cap | $280,746m |
| RiskGrade | 92 |
| Strong Buy | 8 |
| Buy | 10 |
| Neutral | 10 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 28 |

| Time | Volume / Share Price |
| 16:00 | 1,667,484 @ $113.45 |
| 16:00 | 100 @ $113.47 |
| 16:00 | 27,609 @ $113.48 |
| 16:00 | 5,700 @ $113.48 |
| 16:00 | 1,726 @ $113.47 |
You are here: research